Rankings
▼
Calendar
HOWL Q3 2020 Earnings — Werewolf Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
HOWL
Werewolf Therapeutics, Inc.
$41M
Q3 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$6M
Net Income
-$6M
EPS (Diluted)
$-0.68
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$5M
Stock-Based Comp.
$133,000
← FY 2020
All Quarters
Q4 2020 →
